{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T13:03:54Z","timestamp":1785243834714,"version":"3.55.0"},"reference-count":28,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"unspecified","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2026JDKP0106"],"award-info":[{"award-number":["2026JDKP0106"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,6,19]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>According to Chinese clinical practice guidelines, patients with hepatocellular carcinoma (HCC) at high risk of recurrence after curative hepatectomy should have adjuvant transcatheter arterial chemoembolisation (TACE). However, the National Comprehensive Cancer Network and the European Association for the Study of the Liver guidelines take a more conservative stance on the routine use of adjuvant TACE. A recent randomised controlled trial (RCT) found no benefit of adjuvant TACE for patients with early-stage HCC. Given the potential ethical concerns, it is impractical to conduct another RCT. Therefore, we plan to use a target trial emulation (TTE) framework to estimate the effectiveness and safety of adjuvant TACE in patients with resectable HCC, classified as Barcelona Clinic Liver Cancer stage 0-B, with subgroup analyses to identify potential effect-modifying subpopulations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method and analysis<\/jats:title>\n                    <jats:p>A TTE framework using the cloning-censoring-weighting approach with a 4-week grace period will be implemented. Eligible patients will be cloned into the adjuvant TACE and active surveillance groups and artificially censored on deviation from their assigned treatment strategy. Potential confounders will be identified using a directed acyclic graph and inverse probability of censoring weights will be applied to adjust for bias arising from artificial censoring. Subgroup analyses will be prespecified based on the potential sources of treatment-effect heterogeneity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The institutional review board of West China Hospital, Sichuan University, approved this study (Approval No. 2025(1790)). Given the study\u2019s retrospective design and the use of de-identified data, informed consent was waived. The results of this research will be disseminated through publication in a peer-reviewed journal and presentation at scientific conferences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>ChiCTR2600121012.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2026-117956","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T12:20:27Z","timestamp":1785241227000},"page":"e117956","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the effectiveness and safety of adjuvant transcatheter arterial chemoembolisation (TACE) after curative resection for Barcelona Clinic Liver Cancer (BCLC) stage 0-B hepatocellular carcinoma: protocol for a target trial emulation study"],"prefix":"10.1136","volume":"16","author":[{"given":"Zhi","family":"Li","sequence":"first","affiliation":[{"name":"Operating Room, Department of Anesthesiology, West China Hospital, Sichuan University\/West China School of nursing, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizheng","family":"Mi","sequence":"additional","affiliation":[{"name":"Department of Liver Surgery and Liver Transplantation Center, West China Hospital of Sichuan University, Chengdu, China"},{"name":"Department of Medcine II, Heidelberg University Medical Faculty Mannheim, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyan","family":"Li","sequence":"additional","affiliation":[{"name":"West China Hospital\/West China School of Nursing, Sichuan University, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5219-3321","authenticated-orcid":false,"given":"Qiuping","family":"Ren","sequence":"additional","affiliation":[{"name":"Division of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University\/West China School of Nursing, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"2026072805201594000_16.7.e117956.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2025.10.020"},{"key":"2026072805201594000_16.7.e117956.2","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1245\/s10434-019-07646-8","article-title":"Actual 10-Year Survival After Surgical Microwave Ablation for Hepatocellular Carcinoma: A Single-Center Experience in Japan","volume":"26","author":"Ryu","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"2026072805201594000_16.7.e117956.3","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1245\/s10434-016-5713-2","article-title":"Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma","volume":"24","author":"Zheng","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"2026072805201594000_16.7.e117956.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0708857"},{"key":"2026072805201594000_16.7.e117956.5","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"The Lancet"},{"key":"2026072805201594000_16.7.e117956.6","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S1470-2045(15)00198-9","article-title":"Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial","volume":"16","author":"Bruix","year":"2015","journal-title":"The Lancet Oncol"},{"key":"2026072805201594000_16.7.e117956.7","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(23)01796-8","article-title":"Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial","volume":"402","author":"Qin","year":"2023","journal-title":"The Lancet"},{"key":"2026072805201594000_16.7.e117956.8","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2024.08.2279","article-title":"LBA39 Updated efficacy and safety data from IMbrave050: Phase III study of adjuvant atezolizumab (atezo) + bevacizumab (bev) vs active surveillance in patients (pts) with resected or ablated high-risk hepatocellular carcinoma (HCC)","volume":"35","author":"Yopp","year":"2024","journal-title":"Annals of Oncology"},{"key":"2026072805201594000_16.7.e117956.9","doi-asserted-by":"crossref","DOI":"10.1186\/s40880-018-0331-y","article-title":"Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety","volume":"38","author":"Wei","year":"2018","journal-title":"Cancer Commun (Lond)"},{"key":"2026072805201594000_16.7.e117956.10","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s00432-009-0588-2","article-title":"A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular carcinoma","volume":"135","author":"Zhong","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"key":"2026072805201594000_16.7.e117956.11","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-2899"},{"key":"2026072805201594000_16.7.e117956.12","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1097\/HEP.0000000000001233","article-title":"Adjuvant transarterial chemoembolization for hepatocellular carcinoma following curative resection: A randomized, open-label, phase 3 trial","volume":"82","author":"Ma","year":"2025","journal-title":"Hepatology"},{"key":"2026072805201594000_16.7.e117956.13","unstructured":"National Comprehensive Cancer Network. . NCCN Clinical Practice Guidelines in Oncology: Hepatocellular Carcinoma. Version 1.2026. National Comprehensive Cancer Network (NCCN); 2026."},{"key":"2026072805201594000_16.7.e117956.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.08.028"},{"key":"2026072805201594000_16.7.e117956.15","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwv254"},{"key":"2026072805201594000_16.7.e117956.16","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-023-10802-9","article-title":"Efficacy of adjuvant TACE on the prognosis of patients with HCC after hepatectomy: a multicenter propensity score matching from China","volume":"23","author":"Wu","year":"2023","journal-title":"BMC Cancer"},{"key":"2026072805201594000_16.7.e117956.17","doi-asserted-by":"crossref","DOI":"10.1007\/s00423-025-03663-2","article-title":"Prognostic analysis and limited efficacy of adjuvant TACE in hepatocellular carcinoma following hepatectomy: a propensity score-matched study","volume":"410","author":"Peng","year":"2025","journal-title":"Langenbecks Arch Surg"},{"key":"2026072805201594000_16.7.e117956.18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/13645706.2019.1707689","article-title":"Repeated postoperative adjuvant TACE after curative hepatectomy improves outcomes of patients with HCC","volume":"30","author":"Feng","year":"2021","journal-title":"Minim Invasive Ther Allied Technol"},{"key":"2026072805201594000_16.7.e117956.19","first-page":"1198","article-title":"Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: a non-randomized comparative study","volume":"59","author":"Xi","year":"2012","journal-title":"Hepatogastroenterology"},{"key":"2026072805201594000_16.7.e117956.20","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/hepr.14219","article-title":"Adjuvant Transarterial Chemoembolization After Truly Curative Resection Does Not Improve Survival of Patients With Hepatocellular Carcinoma at High Risk of Recurrence: A Target Trial Emulation Study","volume":"55","author":"Su","year":"2025","journal-title":"Hepatol Res"},{"key":"2026072805201594000_16.7.e117956.21","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(07)61602-x"},{"key":"2026072805201594000_16.7.e117956.22","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2025-087179","article-title":"Transparent reporting of observational studies emulating a target trial: the TARGET Statement","volume":"390","author":"Cashin","year":"2025","journal-title":"BMJ"},{"key":"2026072805201594000_16.7.e117956.23","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.21383"},{"key":"2026072805201594000_16.7.e117956.24","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.k182","article-title":"How to estimate the effect of treatment duration on survival outcomes using observational data","volume":"360","author":"Hern\u00e1n","year":"2018","journal-title":"BMJ"},{"key":"2026072805201594000_16.7.e117956.25","doi-asserted-by":"publisher","DOI":"10.2307\/2531021"},{"key":"2026072805201594000_16.7.e117956.26","doi-asserted-by":"crossref","first-page":"839","DOI":"10.2147\/JHC.S370212","article-title":"Extending Surgical Resection for Hepatocellular Carcinoma Beyond Barcelona Clinic for Liver Cancer (BCLC) Stage A: A Novel Application of the Modified BCLC Staging System","volume":"9","author":"Wee","year":"2022","journal-title":"J Hepatocell Carcinoma"},{"key":"2026072805201594000_16.7.e117956.27","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13122984","article-title":"Adjuvant Transarterial Chemoembolization Following Curative-Intent Hepatectomy Versus Hepatectomy Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"13","author":"Esagian","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026072805201594000_16.7.e117956.28","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1104492","article-title":"Adjuvant TACE may not improve recurrence-free or overall survival in HCC patients with low risk of recurrence after hepatectomy","volume":"13","author":"Feng","year":"2023","journal-title":"Front Oncol"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2026-117956","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T12:20:31Z","timestamp":1785241231000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2026-117956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":28,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,28]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/bmjopen-2026-117956"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2026-117956","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}